Get started
Author

Rajaguru Srinivasan

Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial
2015 · Nicholas D James, Matthew R Sydes, et al. · The Lancet · 2,041
Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Prostate Cancer: The Primary Results of the PRONOUNCE Randomized Trial
2021 · Renato D. Lopes, Celestia S. Higano, et al. · Circulation · 164
Docetaxel and/or zoledronic acid for hormone-naïve prostate cancer: First overall survival results from STAMPEDE (NCT00268476).
2015 · Nicholas David James, Matthew Robert Sydes, et al. · Journal of Clinical Oncology · 122
Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trial
2024 · Chris C Parker, Noel W Clarke, et al. · The Lancet · 58
Metformin for patients with metastatic prostate cancer starting androgen deprivation therapy: a randomised phase 3 trial of the STAMPEDE platform protocol
2025 · Silke Gillessen, Laura Murphy, et al. · The Lancet Oncology · 34
PDF
Addition of Docetaxel to First-line Long-term Hormone Therapy in Prostate Cancer (STAMPEDE): Modelling to Estimate Long-term Survival, Quality-adjusted Survival, and Cost-effectiveness
2018 · Beth S. Woods, Eleftherios Sideris, et al. · European Urology Oncology · 27
PDF
Plasma AR Alterations and Timing of Intensified Hormone Treatment for Prostate Cancer
2025 · Gianmarco Leone, Francesco Orlando, et al. · JAMA Oncology · 7
Multi-centre prospective evaluation of cognitive function in patients with metastatic castrate-resistant prostate cancer (mCRPC) treated with abiraterone acetate (AA) or enzalutamide (ENZ): The ACE study.
2024 · Amit Bahl, Amarnath Challapalli, et al. · Journal of Clinical Oncology · 4
PDF
Brachytherapy for advanced prostate cancer bleeding
2008 · R Thurairaja, R Pocock, et al. · Prostate Cancer and Prostatic Diseases · 4
Introduction of adjuvant immunotherapy into the renal surgery pathway: Are eligible patients receiving treatment in time in the UK NHS setting?
2026 · Melissa-Rose Bennett, Grace Liversedge, et al. · Journal of Clinical Urology
P023 Correlation between planning scan rectal diameter and long term control in prostate cancer
2014 · J.M. Mcgrane, R. Srinivasan, et al. · European Urology Supplements
Rectal Volume in Prostate Radiotherapy Planning – Is There Correlation between Diagnostic Staging and Radiotherapy Computed Tomography Planning Scans?
2014 · J. McGrane, R. Powell, et al. · Clinical Oncology
Endocrine hypofunction as a consequence of metastatic cancer
2007 · Rajaguru Srinivasan, Josephine A. Flood, et al. · Society for Endocrinology BES
Works count: 14
Citation count: 2,519
H-index: 7
I10-index: 7
Year
Topic
Type